Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Exclusion Criteria

• •Currently on or has been treated in the past year with insulin regimens that include bolus insulins except the need for insulins in the settings of acute illness or hospitalization
• •History of type 1 diabetes mellitus (T1DM), or diabetic ketoacidosis (DKA), or secondary forms of diabetes such as cystic fibrosis
• •Known hypersensitivity or allergy to insulin-glargine or its excipients or any other insulins
• •Two or more severe hypoglycemic episodes within the prior year
• •Hypoglycemia unawareness defined by history
• •History of proliferative diabetic retinopathy
• •Is currently unstable and/or has moderate-to-severe medical illness in the Investigator's judgment
• •Uncontrolled hypertension (either treated or untreated) defined as a systolic blood pressure ≥ 160 mmHg or a diastolic blood pressure ≥ 100 mmHg at screening
• •History of recent major surgery within 6 months, or minor surgery within 3 months (such as appendectomy) prior to screening visit, or a planned surgery during the study period
• •History of bariatric surgery
• •Active chronic infections
• •Women of child-bearing age who are pregnant, planning pregnancy, breast-feeding, or, if capable of pregnancy, are not practicing contraception if heterosexually active
• •Known hypersensitivity to plastics/polymers/adhesives
• •Known difficulties with adherence of adhesives, bandages, or dressings
• •Participated in any research study within the past 30 days
• •Currently participating in another investigational trial
• •Use of short term or chronic systemic steroids within three months of entry into the study or likelihood that same might be required during the conduct of the study